The analysis focused primarily on basic demographic and tumor-related parameters (age, grade, and stage), without incorporating essential clinical and molecular characteristics such as HER2 status, hormone receptor expression (ER, PR), or molecular subtype. The gene discussed is ERBB2; the disease is neoplasm.